Retatrutide (40 mg Monthly Dose)

Description

Retatrutide (40 mg Monthly Dose)

Effects

Achieves substantial weight loss (up to 24-28% in Phase 3), boosts energy expenditure, reduces appetite, improves glucose control, decreases liver fat.

Applications

Investigational for obesity, type 2 diabetes, metabolic disorders.

Side effects

Gastrointestinal (nausea, vomiting, diarrhea); dose-related heart rate increase (often transient).

Notes

Advanced Phase 3; 40 mg monthly fits experimental weekly protocols.